company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q2,2013-04-01,2013-06-30,2014-08-29 12:55:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q2,2013-04-01,2013-06-30,2014-08-29 12:55:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q2,2013-04-01,2013-06-30,2014-08-29 12:55:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,442000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q2,2013-04-01,2013-06-30,2014-08-29 12:55:31+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,143000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q2,2013-04-01,2013-06-30,2014-08-29 12:55:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2404000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q2,2013-04-01,2013-06-30,2014-08-29 12:55:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2989000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q2,2013-04-01,2013-06-30,2014-08-29 12:55:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2989000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q2,2013-04-01,2013-06-30,2014-08-29 12:55:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,107000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q2,2013-04-01,2013-06-30,2014-08-29 12:55:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q2,2013-04-01,2013-06-30,2014-08-29 12:55:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q2,2013-04-01,2013-06-30,2014-08-29 12:55:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-101000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q2,2013-04-01,2013-06-30,2014-08-29 12:55:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3090000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q2,2013-04-01,2013-06-30,2014-08-29 12:55:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3090000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q2,2013-04-01,2013-06-30,2014-08-29 12:55:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3090000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q2,2013-04-01,2013-06-30,2014-08-29 12:55:31+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,9000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q2,2013-04-01,2013-06-30,2014-08-29 12:55:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3099000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q2,2013-04-01,2013-06-30,2014-08-29 12:55:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2600000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q2,2013-04-01,2013-06-30,2014-08-29 12:55:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.19
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q2,2013-04-01,2013-06-30,2014-08-29 12:55:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2600000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q2,2013-04-01,2013-06-30,2014-08-29 12:55:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.19
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q2,2013-04-01,2013-06-30,2014-08-29 12:55:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2595771.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q2,2013-04-01,2013-06-30,2014-08-29 12:55:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.19
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 07:51:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 07:51:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 07:51:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,503000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 07:51:20+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,148000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 07:51:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2784000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 07:51:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3435000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 07:51:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3435000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 07:51:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,94000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 07:51:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 07:51:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 07:51:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-87000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 07:51:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3522000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 07:51:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3522000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 07:51:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3522000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 07:51:20+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,5000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 07:51:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3527000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 07:51:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2600000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 07:51:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.34
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 07:51:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2600000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 07:51:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.34
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 07:51:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2624040.0
Ocular Therapeutix Inc,OCUL,,0001393434,2013.0,Q3,2013-07-01,2013-09-30,2014-11-12 07:51:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.34
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1575000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,310000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4958000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6843000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6825000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,43000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-141000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-183000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7008000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7008000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7008000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,6000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7014000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2900000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.45
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2900000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.45
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2859752.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 06:48:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.45
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,97000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,97000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,77000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1196000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,535000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4292000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6023000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5946000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,257000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-190000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-446000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6392000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6392000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6392000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,5000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6397000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3000000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.1
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3000000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.1
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3044605.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:18:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.1
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,143000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,143000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,32000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,32000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,111000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1926000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,479000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4482000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6887000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6776000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,412000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-111000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-518000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7294000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7294000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7294000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7294000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15200000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.48
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15200000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.48
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15165612.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:26:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.48
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,505000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,505000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,475000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2216000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,658000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5148000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8022000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7547000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,407000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-407000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7954000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7954000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7954000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7954000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,10700000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.34
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,10700000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.34
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,10652865.0
Ocular Therapeutix Inc,OCUL,,0001393434,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.34
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 07:31:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,426000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 07:31:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,426000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 07:31:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,56000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 07:31:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,56000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 07:31:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,370000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 07:31:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1894000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 07:31:59+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,870000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 07:31:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4719000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 07:31:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7483000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 07:31:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7113000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 07:31:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,505000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 07:31:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,40000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 07:31:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-465000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 07:31:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7578000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 07:31:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7578000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 07:31:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7578000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 07:31:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7578000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 07:31:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21700000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 07:31:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 07:31:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21700000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 07:31:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 07:31:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21362731.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 07:31:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,459000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,459000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,80000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,80000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,379000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2230000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1041000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6743000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10014000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9635000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,405000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,28000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-374000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10009000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10009000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10009000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10009000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,22200000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.45
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,22200000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.45
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,22167274.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 07:42:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.45
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,429000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,429000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,91000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,91000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,338000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2451000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,798000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8263000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11512000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11174000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,406000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,53000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-350000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11524000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11524000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11524000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11524000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24500000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.47
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24500000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.47
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24713597.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 07:15:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.47
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,436000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,436000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,92000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,92000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,344000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2590000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1143000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6886000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10619000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10275000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,408000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,45000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-362000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10637000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10637000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10637000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10637000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23200000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.44
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23200000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.44
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23244162.0
Ocular Therapeutix Inc,OCUL,,0001393434,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.44
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 07:47:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,458000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 07:47:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,458000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 07:47:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,99000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 07:47:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,99000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 07:47:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,359000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 07:47:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2406000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 07:47:25+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1389000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 07:47:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7073000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 07:47:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10868000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 07:47:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10509000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 07:47:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,418000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 07:47:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,87000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 07:47:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-331000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 07:47:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10840000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 07:47:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10840000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 07:47:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10840000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 07:47:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10840000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 07:47:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24600000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 07:47:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.44
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 07:47:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24600000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 07:47:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.44
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 07:47:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24751682.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 07:47:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.44
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:21:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,441000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:21:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,441000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:21:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,105000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:21:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,105000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:21:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,336000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:21:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2973000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:21:29+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1492000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:21:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6978000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:21:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11443000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:21:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11107000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:21:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,418000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:21:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,80000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:21:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-338000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:21:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11445000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:21:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11445000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:21:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11445000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:21:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11445000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:21:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24900000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:21:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.46
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:21:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24900000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:21:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.46
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:21:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24770059.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:21:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.46
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,477000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,477000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,112000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,112000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,365000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2623000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1294000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5686000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9603000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9238000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,426000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,69000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-358000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9596000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9596000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9596000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9596000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24600000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.39
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24600000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.39
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24853880.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:10:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.39
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,511000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,511000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,127000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,127000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,384000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3002000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,2526000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7328000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12856000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12472000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,418000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,68000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-350000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12822000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12822000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12822000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12822000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24800000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.51
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24800000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.51
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24816348.0
Ocular Therapeutix Inc,OCUL,,0001393434,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.51
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:26:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,475000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:26:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,475000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:26:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,115000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:26:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,115000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:26:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,360000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:26:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3276000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:26:35+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,6027000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:26:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6729000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:26:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16032000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:26:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15672000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:26:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,443000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:26:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,92000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:26:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-351000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:26:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16023000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:26:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16023000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:26:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16023000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:26:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16023000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:26:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27600000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:26:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.58
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:26:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27600000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:26:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.58
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:26:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27643746.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:26:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.58
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:17:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,104000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:17:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,104000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:17:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-104000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:17:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3724000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:17:15+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,6832000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:17:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8117000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:17:15+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-438000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:17:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18235000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:17:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18339000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:17:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,468000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:17:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,113000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:17:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-355000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:17:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18694000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:17:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18694000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:17:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18694000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:17:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18694000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:17:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29200000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:17:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.64
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:17:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29200000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:17:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.64
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:17:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29026259.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:17:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.64
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,523000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,523000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,125000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,125000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,398000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4230000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3238000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8126000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15594000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15196000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,491000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,115000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-371000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15567000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15567000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15567000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15567000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28800000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.54
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28800000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.54
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29087654.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:11:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.54
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,925000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,925000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,113000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,113000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,812000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4279000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,903000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7908000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,438000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13528000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12716000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,490000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,104000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-386000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13102000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13102000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13102000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13102000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28800000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.44
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28800000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.44
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28818196.0
Ocular Therapeutix Inc,OCUL,,0001393434,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.44
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:26:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,340000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:26:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,340000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:26:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,80000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:26:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,80000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:26:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,260000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:26:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4771000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:26:35+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,717000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:26:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8227000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:26:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13715000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:26:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13455000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:26:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,486000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:26:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,176000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:26:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-310000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:26:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13765000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:26:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13765000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:26:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13765000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:26:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13765000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:26:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34400000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:26:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:26:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34400000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:26:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:26:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34792848.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:26:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:10:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,648000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:10:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,648000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:10:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,153000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:10:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,153000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:10:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,495000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:10:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4447000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:10:05+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,867000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:10:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8745000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:10:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14059000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:10:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13564000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:10:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,455000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:10:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,215000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:10:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-240000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:10:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13804000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:10:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13804000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:10:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13804000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:10:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13804000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:10:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37300000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:10:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.37
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:10:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37300000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:10:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.37
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:10:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37524512.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:10:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.37
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,498000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,498000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,115000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,115000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,383000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4447000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1067000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9685000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15199000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14816000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,424000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,230000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-194000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15010000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15010000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15010000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15010000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39017922.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,39017922.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39500000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 07:41:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,504000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,504000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,117000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,117000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,387000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5121000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,2291000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10258000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17670000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17283000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,374000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,258000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-116000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17399000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17399000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17399000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17399000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38200000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.42
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38200000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.42
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38115142.0
Ocular Therapeutix Inc,OCUL,,0001393434,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.42
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,492000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,492000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,128000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,128000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,364000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5358000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3347000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11317000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20022000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19658000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1018000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,329000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3223000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2534000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17124000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17124000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17124000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17124000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42251292.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.41
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44174369.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.45
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42251292.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:31:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.41
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,650000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,650000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,552000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,552000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,98000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5058000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,7225000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9414000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21697000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21599000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1627000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,379000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1606000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2854000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24453000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24453000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24453000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24453000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42900000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.57
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42900000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.57
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42910084.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:10:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.57
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,829000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,829000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,806000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,806000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6155000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,6777000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10235000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23167000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23144000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1651000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,308000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5709000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4366000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18778000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18778000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18778000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18778000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46944536.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52713768.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.45
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46900000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 07:41:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2256000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2256000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,839000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,839000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1417000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5551000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,7142000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10125000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22818000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21401000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1805000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,213000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3024000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4616000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26017000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26017000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26017000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26017000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45200000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.53
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45200000.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.44
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45273231.0
Ocular Therapeutix Inc,OCUL,,0001393434,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.53
